SIRT1 and bone cancer: Moreover, SIRT1 activators have exhibited remarkable efficacy and safety against numerous diseases.36, 37 Here, we review the current evidence on the role of SIRT1 in the generation of chronic pain caused by peripheral nerve injury, chemotherapy‐induced peripheral neuropathy, spinal cord injury, bone cancer, and complete Freund's adjuvant (CFA) injection.